Event in Progress:
Discover the latest content that has just been published on Research Tree
Mapfre’s 3Q results were in line with our expectations. The Spanish insurer delivered a robust performance in its P&C business. Nonetheless, the U.S. operations still have a long path to profitability, and we do not see this occurring before the first half of 2025.
Brazil remains a key driver of the company’s overall performance. However, the standout performer was MAPFRE RE, which is steadily increasing in importance with each reporting period. We expect this trend to continue in the future.
Companies: Mapfre (MAP:BME)Mapfre SA (MAP:MCE)
Mapfre saw some positive developments in the second quarter, primarily fuelled by the Brazilian region. However, in other areas, we are still waiting for the realisation of strong pricing in premiums to reflect in the profitability. The company continues to face challenges in the Auto segment, with no immediate signs of improvement.
Despite the improvement in Brazil, our overall perspective on the company remains unchanged. We acknowledge the positive developments in this region, but we are cau
Mapfre experienced a tough quarter, mainly impacted by P&C lines and earthquakes in Turkey. The firm remains under the pressure from high inflation especially on Auto lines.
In our view this profitability miss rules out any hope of a higher DPS than the level paid in recent years, thus leading to a deterioration in the risk-adjusted return profile.
Mapfre reported Q4 22 results ahead of consensus and our expectations. This immediate positive was nonetheless eclipsed as the firm degraded its combined ratio expectations, increasing the risk profile while the expected return was left unchanged (stagnating dividend).
Half-tone Q3 22 results from Mapfre. Net attributable profit was a miss vs. the consensus however the moving parts of the firm’s operations seem to be seeing positive trading.
A tough start into the year for Mapfre, which could potentially be industrial to a certain degree. The firm’s high exposure to motor, coupled with substantial inflation across geographies, proved to be the main killer of the firm’s profitability. The strategic plan’s “aspirational” objectives (defined before the Ukraine war) are so far confirmed, which is reassuring, although potential doubts exist on the Combined ratio objectives.
Companies: Mapfre SA (0NQ2:LON)Mapfre SA (MAP:MCE)
Mapfre’s Q4 results are quite mixed. On one hand, the Non-life business has widely underperformed consensus expectations while, on the other, the Life business has satisfactorily outperformed. With the dividend back to its pre-pandemic level, Mapfre can continue its long recovery.
Mapfre’s technical performance for the quarter recorded low and disappointing levels, in both the Life and Non-life businesses, on the back of normalisation of the combined ratio in Iberia.
However, this miss was offset by Life’s strong financial result and, coupled with the strong performance of Mapfre Re, enabled the Spanish insurer to beat consensus.
Mapfre posted satisfying results for its H1 release and keeps delivering as expected, with guidance reiterated. The insurer’s upside remains, according to us, locked-in and a function of the pace of recovery in Europe and the US, but also especially in LatAm and Brazil.
Mapfre’s Q1 21 release was not so surprising. The Spanish insurer can rely upon better-than-expected results in Iberia saving the day, as the company continues suffering in Brazil and North America. However, this was expected and the latter country looks to be recovering substantially better and faster than Europe, pushing our optimism for Mapfre’s investment recommendation.
Mapfre recorded a strong decline in revenues (-11.8% yoy to €13,277m), driven by COVID-19 that has affected the Life Savings’ sales, currency depreciations (BRL and TRY) and the drop in financial income from investments (-24.9% to €1,226m). The decrease in the net result (-27.7% to c. €271m) came from Mapfre Re while the Insurance units performed well. The group has updated its IBNR reserves to cover the delays in reporting claims. The Board will assess future dividends in Q4 20.
Companies: Mapfre SA
Mapfre reported declining revenues (-4.5% yoy tp €7.33bn) and weaker net earnings (-32% yoy to €127m). This decline was not caused by COVID-19 but by nat cat events. Excluding these, the net earnings stood at €190m, up 3% yoy. The insurer expects to see the consequence of the pandemic in Q2. The market’s volatility should also impact investment income. The capital position at March 2020 was not revealed, but Mapfre said that it was solid enough.
In FY 19, Mapfre’s revenues increased by 7.1% to €28,472m, driven by the improvement in Non-Life premiums (up 2.9% to €17,559m). Iberia continues to be the key profits generator, with an attributable result of €497m (>81% of the group’s). We appreciate the positive trends in the restructured business units in Brazil and the US. However, Mapfre Re needs additional time to reduce its exposure to global risks. The dividend was stable, as announced by the insurer in late 2019.
Our model integrates perfectly the losses announced by Mapfre and relative to the recent nat cat events and disturbances in Chile. We anticipated also a stable dividend for FY 19 and a decreasing Solvency II ratio. The company confirmed the fragility of its profitability and its high dependence on its Spanish business. However, it is still enjoying a solid capital position.
Mapfre reiterated the scenario of H1 19 with better revenues (up 6.5% at current FX to €21,619m) but lower earnings (-12.5% to €463m). The insurer decided to revise the business outlook of MAPFRE ASISTENCIA’s companies in the UK, the US and Canada, leading to goodwill writedowns of €77m. If we take into consideration the impairments of December 2018, the net profut of the group would have been stable relative to 9M 18. The Solvency II ratio remained solid at 198%.
Research Tree provides access to ongoing research coverage, media content and regulatory news on Mapfre SA.
We currently have 16 research reports from 2
Companies: PayPoint plc
Companies: DSW Capital Plc
ORIT: renewables diversified across stage, technology, and geography…
Companies: Octopus Renewables Infrastructure Trust Plc
Kepler | Trust Intelligence
AUM closed FY23 (30 Sep 23) on £37.4bn, 5% up y-o-y. Net flows were slightly negative (-£92m or -0.3% of opening AUM), with investment performance adding £1.8bn. It’s been a tough year for asset managers, but in a London-listed peer group, Impax recorded the second-strongest net flow rate (median -7%, see note). Some experienced heavy (double-digit) net outflows.
A profit fall was due to adjusted operating costs increasing faster than revenue, by 11% from £108.0m to £120.3m. Part of this increas
Companies: Impax Asset Management Group plc
LIFS' announcement this morning discloses strong revenue growth, with sales in the first eleven months up 62%, highlighting the attractiveness of their innovative fire products. These have made them leaders on Amazon both in the UK and in the substantial US market, where they were successfully launched early last year. However, disappointing sales from one partner, combined with enhanced competition, have caused a pull-back in sales forecasts combined with increased losses in the current year; a
Companies: Lifesafe Holdings Plc
Companies: Mercia Asset Management PLC
Companies: CTO HERC LINV ATG
Although the UK now represents a paltry 3.5-4.0% of global equity indices, home bias in the domestic stock market is estimated at c 25% across institutional and retail investors. This persists across asset classes: in the Investment Association universe of open-ended funds, 28.1% of total AUM at the end of September 2023 was invested in UK sectors. This leaves a significant amount of investors' assets exposed to overseas markets that may be unfamiliar and harder to access. In such a situation, t
Companies: AAS HEFT BRFI BRSA PCFT BGS JARA
Capital Access Group
Companies: Vanquis Banking Group PLC
Companies: Distribution Finance Capital Holdings Plc
Hardman & Co Research’s focus is on the nine quoted infrastructure investment companies (IICs) and on the 22 renewable energy infrastructure funds (REIFs), most of which saw their share prices fall during 2022, while the FTSE 100 rose by just 0.9%. In our Quoted UK Infrastructure and Renewable Energy – Prospects for 2023 publication, we have addressed the three key issues of recent months: higher inflation, extremely volatile power prices and rising interest rates.
Companies: DGI9 INPP FTSV UKW GSF SEIT USFP HICL ORIT BSIF TRIG NESF JLEN SEQI HEIT GRP GCP FSFL 3IN PINT RNEW BBGI GSEO DORE L5M TENT GRID CORD HGEN
Hardman & Co
Companies: Duke Royalty Limited
Agronomics (ANIC) invests in cellular agriculture companies. Since mid-2022 it has placed increasing emphasis on companies using precision fermentation technology or providing contract precision fermentation services, as these appear to have greater near-term commercial potential than cultivated meat and seafood. Agronomics’ NAV has risen almost 100% since the inception of the current strategy in April 2019, and looks set to increase further as the company’s portfolio holdings receive regulatory
Companies: Agronomics Limited
Positive interims from Vp this morning highlight another period of growth despite the mixed market backdrop. The results again illustrate the benefit of Vp’s diverse mix of specialist activities, with the quality of earnings confirmed by further growth in operating margin (now 13.9%) and ROCE (14.7%).
Strategic priorities include continued progress with ESG initiatives and a greater emphasis on Digital, with more on this likely to follow later in the year.
We maintain our Fair Value estimate o
Companies: Vp plc
Duke has released its H1/24A interim results for the period ending 30th September 2023 that are in-line with expectations. Recurring cash revenues increased 17% to £12.2m, whilst total cash revenues increased 35% to £14.1m. The portfolio continues to be resilient despite macroeconomic headwinds, and c£18m of capital was deployed across new and existing investments. We iterate a 1-year price target of 45p based on a target FCF yield of 8%.